These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840 [TBL] [Abstract][Full Text] [Related]
25. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667 [TBL] [Abstract][Full Text] [Related]
26. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Jonas JB; Söfker A Am J Ophthalmol; 2001 Sep; 132(3):425-7. PubMed ID: 11530068 [TBL] [Abstract][Full Text] [Related]
27. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: principles and practice. Vedantham V; Kim R Indian J Ophthalmol; 2006 Jun; 54(2):133-7. PubMed ID: 16770036 [TBL] [Abstract][Full Text] [Related]
28. [Triamcinolone in the treatment of the diabetic macular edema--one-year results]. Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654 [TBL] [Abstract][Full Text] [Related]
30. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema. Shimura M; Yasuda K; Minezaki T; Noma H Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783 [TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone acetonide for diabetic macular edema. Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A Retina; 2005; 25(7):828-34. PubMed ID: 16205559 [TBL] [Abstract][Full Text] [Related]
32. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow. Cekiç O; Bardak Y; Tiğ SU; Demirkol A; Ekim MM; Altintaş O; Yeşildağ A; Oyar O Int Ophthalmol; 2007 Oct; 27(5):313-9. PubMed ID: 17505781 [TBL] [Abstract][Full Text] [Related]
34. Diabetic macular edema before and after intravitreal triamcinolone injection. Ramezani A; Tabatabaie H; Ahmadieh H Korean J Ophthalmol; 2007 Jun; 21(2):95-9. PubMed ID: 17592240 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes. Barak A; Regenbogen M; Goldstein M; Loewenstein A Isr Med Assoc J; 2006 Feb; 8(2):83-7. PubMed ID: 16544727 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study). Paccola L; Costa RA; Folgosa MS; Barbosa JC; Scott IU; Jorge R Br J Ophthalmol; 2008 Jan; 92(1):76-80. PubMed ID: 17965109 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial. Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504 [TBL] [Abstract][Full Text] [Related]
38. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology. Sørensen TL; Haamann P; Villumsen J; Larsen M Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560 [TBL] [Abstract][Full Text] [Related]